Tag Archives: Alcon

Philips HealthSuite digital platform selected for the development of Alcon SMART Suite ophthalmology care platform

Alcon SMART Suite, powered by Philips’ HealthSuite digital platform, aims to drive innovation in ophthalmology delivering personalized and seamless end-to-end care for cataract patients AMSTERDAM, 24-Oct-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, … Read the full press release

Alcon announces an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market

Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation BASEL, 31-Aug-2018 — /EuropaWire/ — Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from … Read the full press release

Novartis’ Alcon AcrySof IQ PanOptix intraocular lens unveils new data showing significantly improved near and intermediate distance vision

Better visual outcomes for patients with the AcrySof IQ PanOptix intraocular lens at near and intermediate distance vision[1]  Detailed findings presented at World Ophthalmology Congress 2018 Recent survey reveals 82% of people 60+ are willing to have advanced surgical options … Read the full press release

Alcon to introduce Clareon®intraocular lens at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress in Lisbon

Clareon® intraocular lens (IOL) implanted with a unique single-use automated pre-loaded delivery system debuts with new data presentations Congress program highlights Alcon’s 70-year legacy of innovation including 100 million AcrySof® IOL implants  New analyses show efficacy and safety of CyPass® Micro-Stent in patients … Read the full press release

Eye care leader Alcon to launch the CyPass® Micro-Stent at AAO annual meeting in Chicago

Alcon to host first live training program on the use of the CyPass® Micro-Stent, a minimally invasive glaucoma surgical device to treat cataract patients with mild to moderate primary open-angle glaucoma Two-year safety and efficacy data from landmark COMPASS study … Read the full press release